Valuation dashboard for Baird Medical Investment Holdings Limited (BDMD) with P/E N/A, P/B 1.25, EV/EBITDA -4.37 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions.
Analysis Summary
Baird Medical Investment Holdings Limited reported revenue of $22.5M in the most recent fiscal year, growing at a 5-year CAGR of 4.5%.
Trailing-twelve-month margins: gross margin 85.6%, operating margin -58.5%, net margin -65.2%.
At the current price of $1.06, BDMD has negative trailing earnings (P/E not meaningful) and an ROE of -48.29%. Market capitalisation stands at $45M.
Balance sheet quality for BDMD: current ratio of 1.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.25 |
| EV / EBITDA | -4.37 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $2.20 |
| vs Current Price | +108.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BDMD | Baird Medical Investment Holdings Limited | $45M | 1.25 | -48.3% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $1.06 |
| Market Cap | $45M |
| Exchange | NASDAQ |
| Country | CN |
Profitability
| Return on Equity | -48.29% |
| Return on Invested Capital | -26.96% |
| Return on Assets | -21.63% |
| Gross Margin | 85.63% |
| Operating Margin | -58.52% |
| Net Margin | -65.20% |
Related companies: BDSX · BEAT · CTSO · ECOR · FGEN · ICCM · NMTC
Explore sector: Healthcare · Medical - Devices
More sections of BDMD: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks